{
  "accessLevel": "public",
  "bureauCode": [
    "020:00"
  ],
  "contactPoint": {
    "fn": "Cavin Ward-Caviness",
    "hasEmail": "mailto:ward-caviness.cavin@epa.gov"
  },
  "description": "Data is tabular data containing metabolite concentrations, cardiovascular disease biomarkers, individual-level demographics, medication usage, and behavioral confounders (physical activity, smoking, alcohol usage). This dataset is not publicly accessible because: This data is not owned by the EPA. It can be accessed through the following means: The data can be accessed by contacting the lead study author - Susanne Rospleszcz. Format: Data is tabular data containing metabolite concentrations, cardiovascular disease biomarkers, individual-level demographics, medication usage, and behavioral confounders (physical activity, smoking, alcohol usage). \n\nThis dataset is associated with the following publication:\nMaushagen, J., N. Addine, C. Schuppert, C. Ward-Caviness, J. Nattenmueller, J. Adamski, A. Peters, F. Bamberg, C. Schlett, R. Wang-Sattler, and S. Rospleszcz. Serum metabolite signatures of cardiac function and morphology in individuals from a population-based cohort.   Biomarker Research. BioMed Central Ltd, London,  UK, 12(31): s40364-024-00578-w, (2024).",
  "distribution": [],
  "identifier": "https://doi.org/10.23719/1532109",
  "keyword": [
    "MRI",
    "cardiovascular disease",
    "fatty acids",
    "metabolomics"
  ],
  "license": "https://pasteur.epa.gov/license/sciencehub-license-non-epa-generated.html",
  "modified": "2024-03-05",
  "programCode": [
    "020:000"
  ],
  "publisher": {
    "name": "U.S. EPA Office of Research and Development (ORD)",
    "subOrganizationOf": {
      "name": "U.S. Environmental Protection Agency",
      "subOrganizationOf": {
        "name": "U.S. Government"
      }
    }
  },
  "references": [
    "https://doi.org/10.1186/s40364-024-00578-w",
    "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10916302"
  ],
  "rights": null,
  "title": "Metadata for: Serum metabolite signatures of subclinical cardiovascular disease in individuals from a population-based cohort"
}